Early Markers of Neurodevelopmental Risk in Congenital Heart Disease

先天性心脏病神经发育风险的早期标志

基本信息

  • 批准号:
    8294408
  • 负责人:
  • 金额:
    $ 13.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ismee Williams is an Assistant Professor in the Division of Pediatric Cardiology at Columbia University with a long-term goal to become an independent clinical investigator of perinatal contributors to neurodevelopmental outcomes in the congenital heart disease (CHD) population. Dr. Williams' short-term goal is to acquire the skill set and experience needed to launch her career. To date, Dr. Williams has benefitted greatly from the clinical research environment of Columbia University which includes the resources made available by the NIH-funded Clinical and Translational Science Award (CTSA). Dr. Williams trained in the conduct of patient oriented research and received a Masters in Biostatistics from the Mailman School of Public Health during the last two years of her fellowship. Dr. Williams was named a K12 TRANSFORM scholar during her first year as an attending and received a $50,000 CTSA sponsored pilot award the following year. Over the past year, Dr. Williams has directed a multidisciplinary feasibility study that is the basis for the proposed protocol to investigate potential risk factors associated with neurocognitive outcomes in patients with complex CHD. The proposed study is innovative in its intent to investigate perinatal markers of risk. Using a prospective observational cohort design, Dr. Williams will enroll 50 fetuses with CHD and 25 normal controls in order to 1) further characterize autonomic regulation in CHD fetuses, 2) test associations between fetal autonomic regulation and fetal cerebral blood flow, and 3) test associations between these two fetal measures and infant and toddler neurologic outcomes including autonomic regulation, cerebral function measured by high-density EEG, and neurodevelopment assessed by the Bayley Scale of Infant Development-III at 18-months. The career development plan includes a closely mentored program under the supervision of Dr. William Fifer, a developmental psychobiologist, with focused training in perinatal autonomic assessment. In addition, Dr. Philip Grieve will train Dr. Williams in the procedure of infant high-density EEG assessment. Increased understanding of these topics will allow Dr. Williams to become a more effective clinical perinatal investigator of neurodevelopmental outcomes in CHD. PUBLIC HEALTH RELEVANCE: This study is important as: 1) CHD is the most common group of birth defects, 2) survival following CHD surgery is increasing, and 3) survivors of complex CHD often (>50%) have neurologic difficulties, including learning delay and mental retardation the causes of which are largely unknown. Identification of early markers of adverse neurologic outcomes will allow the implementation of timely preventative and therapeutic services.
描述(由申请人提供):Ismee Williams是哥伦比亚大学小儿心脏病学系的助理教授,其长期目标是成为先天性心脏病(CHD)人群神经发育结果的独立临床临床研究者的独立临床研究者。威廉姆斯博士的短期目标是获得启动职业所需的技能和经验。迄今为止,威廉姆斯博士从哥伦比亚大学的临床研究环境中受益匪浅,其中包括由NIH资助的临床和转化科学奖(CTSA)提供的资源。威廉姆斯博士接受了以患者为导向的研究进行培训,并在她的奖学金的最后两年中获得了邮政公共卫生学院生物统计学的硕士学位。威廉姆斯博士在参加的第一年被任命为K12转型学者,并于次年获得了50,000美元的CTSA赞助飞行员奖。在过去的一年中,威廉姆斯博士指导了一项多学科的可行性研究,该研究是拟议方案研究复杂CHD患者中与神经认知结果相关的潜在危险因素的基础。拟议的研究旨在研究风险围产期标志。 Using a prospective observational cohort design, Dr. Williams will enroll 50 fetuses with CHD and 25 normal controls in order to 1) further characterize autonomic regulation in CHD fetuses, 2) test associations between fetal autonomic regulation and fetal cerebral blood flow, and 3) test associations between these two fetal measures and infant and toddler neurologic outcomes including autonomic regulation, cerebral function measured by高密度的脑电图和神经发育由婴儿发育的Bayley量表在18个月时评估。职业发展计划包括在发育心理学家威廉·菲尔德(William Fifer)博士的监督下进行的一项密切指导的计划,并重点培训了围产期自治评估。此外,菲利普·格里夫(Philip Grieve)博士还将培训威廉姆斯博士的婴儿高密度脑电图评估。对这些主题的越来越多将使威廉姆斯博士成为CHD中神经发育结果的更有效的临床围产期研究者。 公共卫生相关性:这项研究很重要,因为:1)CHD是最常见的先天缺陷群体,2)CHD手术后的存活率正在增加,并且3)复杂CHD的幸存者经常(> 50%)具有神经系统困难,包括学习延迟和智力障碍,其原因很大。对不良神经系统结局的早期标记的识别将允许实施及时的预防和治疗服务。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Ismee A. Williams其他文献

LINEAR GROWTH FAILURE IS ASSOCIATED WITH WORSE NEURODEVELOPMENTAL OUTCOME IN INFANTS WITH SINGLE VENTRICLE PHYSIOLOGY
  • DOI:
    10.1016/s0735-1097(11)60420-8
    10.1016/s0735-1097(11)60420-8
  • 发表时间:
    2011-04-05
    2011-04-05
  • 期刊:
  • 影响因子:
  • 作者:
    Chitra Ravishankar;Victor Zak;David Bellinger;Amanda Cook;J. William Gaynor;Nancy Ghanayem;Catherine Krawczeski;Daniel J. Licht;Lynn Mahony;Jane Newburger;Victoria Pemberton;Teresa Atz;Svetlana Khaikin;Renee Sananes;Ismee A. Williams;Richard V. Williams;Daphne Hsu
    Chitra Ravishankar;Victor Zak;David Bellinger;Amanda Cook;J. William Gaynor;Nancy Ghanayem;Catherine Krawczeski;Daniel J. Licht;Lynn Mahony;Jane Newburger;Victoria Pemberton;Teresa Atz;Svetlana Khaikin;Renee Sananes;Ismee A. Williams;Richard V. Williams;Daphne Hsu
  • 通讯作者:
    Daphne Hsu
    Daphne Hsu
共 1 条
  • 1
前往

Ismee A. Williams的其他基金

Early Markers of Neurodevelopmental Risk in Congenital Heart Disease
先天性心脏病神经发育风险的早期标志
  • 批准号:
    8097265
    8097265
  • 财政年份:
    2010
  • 资助金额:
    $ 13.11万
    $ 13.11万
  • 项目类别:
Early Markers of Neurodevelopmental Risk in Congenital Heart Disease
先天性心脏病神经发育风险的早期标志
  • 批准号:
    8474805
    8474805
  • 财政年份:
    2010
  • 资助金额:
    $ 13.11万
    $ 13.11万
  • 项目类别:
Early Markers of Neurodevelopmental Risk in Congenital Heart Disease
先天性心脏病神经发育风险的早期标志
  • 批准号:
    7893937
    7893937
  • 财政年份:
    2010
  • 资助金额:
    $ 13.11万
    $ 13.11万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Modeling genetic contributions to biliary atresia
模拟遗传对胆道闭锁的影响
  • 批准号:
    10639240
    10639240
  • 财政年份:
    2023
  • 资助金额:
    $ 13.11万
    $ 13.11万
  • 项目类别:
Robust, Contrast-Free Functional Renal MRI
稳健、无对比的功能性肾脏 MRI
  • 批准号:
    10578551
    10578551
  • 财政年份:
    2023
  • 资助金额:
    $ 13.11万
    $ 13.11万
  • 项目类别:
Abdominal Pain in Older Patients in Emergency Departments
急诊科老年患者的腹痛
  • 批准号:
    10739136
    10739136
  • 财政年份:
    2023
  • 资助金额:
    $ 13.11万
    $ 13.11万
  • 项目类别:
Adipose Dysfunction, Imaging, Physiology, and Outcomes with SGLT2i's for Sleep Apnea: The ADIPOSA Study
脂肪功能障碍、影像学、生理学和 SGLT2i 治疗睡眠呼吸暂停的结果:ADIPOSA 研究
  • 批准号:
    10583864
    10583864
  • 财政年份:
    2023
  • 资助金额:
    $ 13.11万
    $ 13.11万
  • 项目类别:
Understanding associations between timing of physical activity and health outcomes in young adults
了解年轻人身体活动时间与健康结果之间的关联
  • 批准号:
    10747742
    10747742
  • 财政年份:
    2023
  • 资助金额:
    $ 13.11万
    $ 13.11万
  • 项目类别: